Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
October 22, 2025
For immediate release
The four articles each explore a different aspect of how fertility care intersects with cancer treatment:
- Fertility preservation for cancer: referral guidelines, treatment options, and specific considerations: As cancer incidence and survival rates increase among individuals of reproductive age, fertility preservation has become a critical component of comprehensive cancer care. Common cancer treatments like chemotherapy and radiation can significantly impair reproductive potential, yet access to fertility preservation remains inconsistent. The research paper outlines the best practices for fertility preservation for cancer patients as well as the current barriers to fertility care – including the high cost and lack of insurance coverage.
- Unassisted pregnancy rates and outcomes in cancer survivors: a systematic review: The research shows that although unassisted pregnancy is possible for patients diagnosed with cancer, certain cancers and treatments – including breast cancer – are associated with decreased live birth rates and increased complications. Individualized fertility preservation counseling throughout the cancer diagnosis and treatment process is an important aspect of comprehensive cancer care that helps patients make informed decisions about their future fertility.
- Infertility evaluation and treatment in cancer survivors: The research underscores the unique fertility needs of cancer patients, concluding that IVF remains an essential, often irreplaceable option for fertility preservation and family building.
- Fertility preservation and mental health among cancer patients of reproductive age: The paper makes the case that integrating mental health into clinical models of oncofertility care delivery is critical, highlighting how most patients who preserve fertility report feeling confident in their decision, even if preservation outcomes are not favorable, whereas patients who do not preserve fertility report higher rates of decisional regret.
As of January 1, 2025, about 18.6 million people living in the United States have a history of cancer, and this number is projected to exceed 22 million by 2035.
“Patients diagnosed with cancer already face extraordinary challenges, and worrying about whether they will have the chance to build a family should not be another burden,” said ASRM President Dr. Elizabeth Ginsburg. “IVF is often the only evidence-based treatment that allows many cancer patients to preserve their fertility and maintain hope for the future, but most insurance companies do not cover the treatment, even for cancer survivors. The US must mandate insurance coverage for IVF and fertility preservation treatments to ensure no cancer patient needs to choose between treatment and building a family.”
ASRM continues to advocate for policies that expand, rather than restrict, access to fertility care, particularly for patients whose medical circumstances, like a cancer diagnosis, make timely access to IVF critical.
Fertility and Sterility is the flagship publication of The American Society for Reproductive Medicine (ASRM). The peer-reviewed journal runs internationally and is published monthly.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as well
Dr. Robert Brannigan Inaugurated President of the American Society for Reproductive Medicine
Robert E. Brannigan, MD, becomes ASRM President, bringing leadership in male fertility, fertility preservation, and reproductive urology to the forefront.
American Society for Reproductive Medicine Honors 2025 Awardees at Scientific Congress & Expo in San Antonio, TX
ASRM honors leaders in reproductive medicine with 2025 Scientific Congress Awards for research, service, education, and clinical innovation.
Fertility and Sterility Publishes Editorial Exploring the Origins of “Restorative Reproductive Medicine” and Why Modern Fertility Care Must Remain Comprehensive
Restorative reproductive medicine overlooks IVF, male-factor care, and the need for full-spectrum fertility treatment using modern technologies.
Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
New ASRM‑supported research highlights key IVF and fertility preservation access needs for cancer patients — particularly during Breast Cancer Awareness Month.The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Topic Resources
View more on the topic of cancer and fertility
Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
New ASRM‑supported research highlights key IVF and fertility preservation access needs for cancer patients — particularly during Breast Cancer Awareness Month. View the Press Release
Medication Administration
Is CPT code 96402 applicable to a Depo-Lupron or Zoladex injection by nurse at REI practice, even if there is no diagnosis of cancer? View the Answer
Fertility Preservation Consult
What code are we supposed to use for counseling regarding fertility preservation for an individual with cancer... View the Answer
D&C Under Ultrasound Guidance
What are the CPT codes and ICD-10 codes for coding a surgical case for a patient with history of Stage B adenocarcinoma of the cervix ... View the Answer
Cycle Monitoring Fertility Preservation
If the patient is undergoing ultrasound tracking visits for fertility preservation, what I ICD-10 code do you use for the monitoring? View the Answer
Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review (2019)
Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions. View the Joint Statement
Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion (2018)
Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. View the Committee Opinion
Best practices of ASRM and ESHRE: a journey through reproductive medicine (2012)
ASRM and ESHRE are the two largest societies in the world whose members comprise the major experts and professionals working in reproductive medicine. View the Committee Joint GuidelineTopic Resources
View more on the topic of fertility preservation
Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
New ASRM‑supported research highlights key IVF and fertility preservation access needs for cancer patients — particularly during Breast Cancer Awareness Month. View the Press Release
Fertility and Sterility On Air - Unplugged: October 2025
Circadian rhythms, bariatric surgery, IL‑22, and mTOR’s role in fertility—hear expert insights in ASRM’s latest Fertility & Sterility Unplugged episode. Listen to the Episode
Fertility and Sterility On Air - Roundtable: Egg Sharing
Experts debate the ethics of egg sharing and split cycles, exploring patient autonomy, informed consent, diversity, and equitable fertility care. Listen to the Episode
The Heart of Advocacy Day
Advocacy is a commitment to push through discomfort for the sake of future progress. Learn more about RESOLVE's Advocacy Day in partnership with ASRM.
Oocyte cryopreservation
We code 89337 (cryopreservation of oocytes) for the entire oocyte preservation cycle, including monitoring visits. View the Answer
Reimplantation of cryopreserved ovarian tissue
What is the correct code for laparoscopic reimplantation of ovarian tissue? View the Answer
Z Codes Vs. Procedure Codes For Fertility Preservation Counseling
I am trying to understand better when to use the procreative management code vs the fertility preservation counseling and procedure codes. View the Answer
Elective fertility preservation is ART
From an insurance standpoint, is fertility preservation is considered an assisted reproductive technology or would it be branched under other? View the Answer
Oocyte Preservation Consult
Our center performs oocyte preservation procedures for women looking to preserve their fertility. View the Answer
Fertility Preservation Consult
What code are we supposed to use for counseling regarding fertility preservation for an individual with cancer... View the Answer
Coding For Ovarian Tissue Cryopreservation
Now that ASRM has removed the "experimental" designation from ovarian tissue cryopreservation what CPT code should be used instead of 0058T? View the Answer
Cycle Monitoring Fertility Preservation
If the patient is undergoing ultrasound tracking visits for fertility preservation, what I ICD-10 code do you use for the monitoring? View the Answer
Fertility Preservation
A summary of codes for Fertility Preservation compiled by the ASRM Coding Committee. View the Coding Summary
Access to fertility services by transgender and nonbinary persons: an Ethics Committee opinion (2021)
The provision of fertility services to transgender individuals and the denial of access to fertility services is not justified. View the Committee Opinion
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion (2019)
Expert guidelines on fertility preservation options—oocyte, embryo, ovarian and testicular tissue cryopreservation and counseling before gonadotoxic treatment. View the Committee Opinion
Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review (2019)
Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions. View the Joint Statement
Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion (2018)
Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. View the Committee Opinion
Fertility Preservation Special Interest Group (FPSIG)
The FPSIG promotes knowledge on infertility induced by cancer therapy and other medical treatments. Learn more about FPSIGTopic Resources
View more on the topic of in vitro fertilization (IVF)
Fertility and Sterility Publishes Editorial Exploring the Origins of “Restorative Reproductive Medicine” and Why Modern Fertility Care Must Remain Comprehensive
Restorative reproductive medicine overlooks IVF, male-factor care, and the need for full-spectrum fertility treatment using modern technologies. View the Press Release
Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
New ASRM‑supported research highlights key IVF and fertility preservation access needs for cancer patients — particularly during Breast Cancer Awareness Month. View the Press Release
American Society for Reproductive Medicine Reacts to White House Announcement on IVF Coverage
ASRM applauds the White House’s first steps toward IVF access but underscores that true equity demands mandatory insurance coverage. View the Press Release
Fertility and Sterility On Air - Unplugged: September 2025
Explore optimal IVF trigger timing, dual trigger insights, and how TikTok shapes endometriosis info—on F&S Unplugged with ASRM experts. Listen to the Episode
How to Bill to Insurance When Treatment Cycle is Canceled
If a patient is self-paying for treatment and the patient’s IVF or FET cycle is canceled, what would be the appropriate code to use to send View the Answer
Billing Same Sex Male Donor Cycles
If both male partners provide sperm for the fertilization process, would we obtain authorization/bill for the fertilization process for View the Answer
Correct Code to use for using Zymot to Prepare Sperm for Insemination
We recently started using ZyMot to prepare sperm for insemination. Is 89260 the correct CPT code to use? Do you View the Answer
Fertility and Sterility On Air - Roundtable: Egg Sharing
Experts debate the ethics of egg sharing and split cycles, exploring patient autonomy, informed consent, diversity, and equitable fertility care. Listen to the Episode
ASRM PRIMED Cohort Members—Including Physicians, Providers, and Experts—Meet with Congressional Offices to Advocate for IVF Access & Educate About Realities of Restorative Reproductive Medicine
ASRM PRIMED cohort meets Congress to push for IVF access, clarify risks of restorative reproductive medicine, and defend science‑based fertility care. View the Press Release
ASRM Hosts Capitol Hill Briefing for Policymakers & Congressional Staff to Hear From Providers & Patients About Importance of IVF Access, Realities and Limitations of Restorative Reproductive Medicine
ASRM briefing united lawmakers, physicians & patients on IVF access, exposing RRM limits and urging policies to expand fertility care options. View the Press Release
SRS Warns Against Limiting Access to IVF Under the Guise of “Restorative” Care
SRS, an ASRM affiliate, advocates evidence-based reproductive surgery and full-spectrum fertility care for conditions like endometriosis, fibroids, and PCOS. View the Press Release
ASRM Letter to the International Institute for Restorative Reproductive Medicine (IIRRM)
ASRM responds to IIRRM, affirming patient-centered infertility care, IVF access, and evidence-based treatment while supporting respectful dialogue. View the ASRM letter to the IIRRM
Don’t be fooled: There is no substitute for IVF
IVF is essential for many families. Restorative Reproductive Medicine is no substitute, risking access to proven fertility care in the U.S. View the OpEd
Fertility and Sterility On Air - Roundtable: State Advocacy
Experts share strategies for IVF advocacy, combating misinformation, and building connections with policymakers to protect reproductive rights and access. Listen to the Episode
Journal Club Global en Español: AMMR 2025
Experts discuss chaotic embryo classification, PGT-A rebiopsy outcomes, embryo quality, biopsy techniques, and transfer protocols for mosaic embryos. View the Video
Fertility and Sterility Publishes Editorial Piece on How Restorative Reproductive Medicine Violates Reproductive Autonomy and Informed Consent
Editorial in Fertility and Sterility warns that Restorative Reproductive Medicine spreads stigma, delays care, and undermines IVF and patient autonomy. View the Press Release
Fertility and Sterility On Air - Unplugged: August 2025
Podcast covers IVF toxicology, embryo vitrification, fibroid research, and lab automation with AI, exploring fertility risks, outcomes, and innovations. Listen to the Episode
F&S Reports Publishes Editorial Piece on the Unscientific Nature of the Arguments for “Restorative Reproductive Medicine” and Why We Need to Understand Them
F&S Reports editorial critiques “Restorative Reproductive Medicine” as unscientific, faith-driven, and a threat to evidence-based IVF care and reproductive rights. View the Press Release
Fertility and Sterility On Air - TOC: August 2025
Fertility and Sterility marks 75 years with debates on PGT-A, Dobbs impacts, ART risks, contraception trends, and advances shaping reproductive medicine. Listen to the Episode
ASRM, Leading Medical Organizations Urge National Governors Association to Reject ‘Restorative Reproductive Medicine’ in Open Letter
Medical groups urge governors to reject Restorative Reproductive Medicine laws, defending evidence-based infertility care and IVF access. View the Press Release
Fertility and Sterility On Air - Unplugged: July 2025
Explore IVF innovations, mental health in MRKH care, and beta book practices in this deep dive from F&S On Air with expert insights and critical updates. Listen to the Episode
Fertility and Sterility On Air - TOC: July 2025
Explore July 2025’s Fertility & Sterility insights on ART births, FET protocols, progesterone safety, uterine transplants, and adhesion prevention research. Listen to the Episode
Journal Club Global LIVE at MRSi 2025: Sibling Oocyte Studies in ART
Experts discuss sibling oocyte trials, PIEZO-ICSI, and microfluidics in ART, evaluating outcomes, design limits, lab impact, and clinical implications. View the Video
Fertility and Sterility On Air - Live from the PCRS 2025 Annual Meeting
Explore cutting-edge fertility research from PCRS 2025—PGT-A, embryo screening, cost-effective protocols, and gamete storage breakthroughs. Listen to the Episode
Fertility and Sterility On Air - TOC: June 2025
Stay updated on global reproductive medicine with Fertility & Sterility On Air—insights, debates, and journal highlights hosted by leading experts. Listen to the Episode
Fertility & Sterility Publishes New Study Validating IVF Data Accuracy of a National Commercial Claims Database, Comparable with National IVF Registries
New study validates IVF data from commercial claims database, supporting its use by policymakers, employers, and researchers in expanding IVF coverage. View the Press Release
ASRM Statement on Palm Springs Bombing
ASRM condemns the Palm Springs bombing, stands with victims, and urges action to protect healthcare providers from violence and harassment. View the Press Release
ASRM Center for Policy & Leadership Releases Fact Sheet on Misleading Terminology, “Restorative Reproductive Medicine” and "Ethical IVF"
ASRM exposes how terms like “RRM” and “ethical IVF” mislead and restrict IVF access, urging science-based policies that support all paths to family building. View the Press Release
Just the Facts: “Restorative Reproductive Medicine” and “Ethical IVF” are Misleading Terms That Threaten Access
Terms like “restorative reproductive medicine” and “ethical IVF” mislead and restrict access to proven fertility care like IVF. Evidence must guide policy. View the advocacy resource
Fertility and Sterility On Air - TOC: May 2025
Explore new fertility research on IVF triggers, thyroid autoimmunity, prednisone use, and genetic impacts in this expert-led review of May 2025’s F&S journal. Listen to the Episode
US IVF usage increases in 2023, leads to over 95,000 babies born
SART releases 2023 IVF data during National Infertility Awareness Week, showing record births and rising demand for ART to support growing families. View the Press Release
Just the Facts: The Safety of In Vitro Fertilization (IVF)
IVF is a safe, proven medical procedure with extensive research backing. Though risks exist, advancements and strict monitoring ensure most IVF babies are healthy. View the advocacy resource
Assisted Reproductive Technology (ART) Oversight: Lessons for the United States from Abroad
A comprehensive analysis of global Assisted Reproductive Technology (ART) regulations, comparing policies, accessibility, and ethical considerations in various countries. View the advocacy resource
Just the Facts: IVF Policy Priorities
ASRM advocates for expanded IVF access, urging policy solutions that prioritize patient care, inclusivity, and medical decision-making free from political interference. View the advocacy resource
Hormonal Induction of Endometrial Receptivity for Fresh or Frozen Embryo Transfer
Explore Dr. Paulson's insights on endometrial receptivity and hormonal preparation in IVF, egg donation, and surrogacy, highlighting estrogen and progesterone roles. View the ASRMed Talk Video
The use of preimplantation genetic testing for aneuploidy: a committee opinion (2024)
PGT-A use in the U.S. is rising, but its value as a routine IVF screening test is unclear, with mixed results from various studies. View the Committee Opinion
Journal Club Global from ANZSREI 2024: Debate Unexplained infertility; Straight to IVF?
ANZSREI 2024 debate: Should unexplained infertility go straight to IVF? Experts discuss pros, cons, and alternative treatments. No clear consensus reached. View the Video
Who to bill for gestational carrier services if intended parents have insurance?
I wanted to inquire about guidelines for billing services to a surrogate’s insurance company if intended parents purchased the insurance coverage. View the Answer
Performing MD is not the Doctor of Record
Currently we are billing the performing provider as the service provider and the Doctor of Record as the billing provider. View the Answer
Journal Club Global: Oral Progestin For Ovulation Suppression During IVF
Live broadcast from the 2024 Midwest Reproductive SymposiumInternational in Chicago, IL View the Video
Billing for assisted hatching at biopsy and transfer
We would also like to know if you can bill assisted hatching with biopsy and then assisted hatching again during the transfer cycle. View the Answer
What support for IVF looks like
Bipartisan support for IVF, that is responsible for the birth of over 2% of all babies born in the USA each year, will ensure that families continue to grow. View the advocacy resource
It takes more than one
Why IVF patients often need multiple embryos to have a baby View the advocacy resource
Oversight of IVF in the US
In the US, medical care is regulated by a complex and comprehensive network of federal and state regulations and professional oversight. View the advocacy resource
Financial ‘‘risk-sharing’’ or refund programs in assisted reproduction: an Ethics Committee opinion (2023)
Financial ‘‘risk-sharing’’ fee structures in programs charge patients a higher initial fee but provide reduced fees for subsequent cycles. View the Committee Document
Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline (2023)
Ovarian hyperstimulation syndrome is a serious complication associated with assisted reproductive technology. View the guideline
Billing IVF lab work
We typically bill our IVF Lab work under the rendering provider who performs the VOR. Who should be the supervising provider for embryology billing? View the Answer
IVF Lab Automation
Automation in IVF labs is progressing, focusing on cryopreservation, dish prep, and data integration. Challenges remain in standardizing processes and material safety. View the ASRMed Talk Video
Journal Club Global: IVM in Clinical Practice: An Idea Whose Time Has Come?
In vitro maturation (IVM) has the potential to make IVF cheaper, safer, and more widely accessible to patients with infertility. View the Video
Limited ultrasound performed by RN
Would it be appropriate to bill a 99211 when an RN is doing a limited ultrasound and documenting findings during an IUI or IVF treatment cycle? View the Answer
CPT 89253 and 89254 for Assisted hatching
Can I bill CPT codes 89253 and 89254 together? If yes, do I need a modifier on any of the codes? View the Answer
IVF cycle management and facility fees, an overview
How should IVF Cycle Management be coded? View the Answer
Journal Club Global - What is the optimal number of oocytes to reach a live-birth following IVF?
The optimal number of oocytes necessary to expect a live birth following in vitro fertilization remains unclear. View the Video
Patient Education
What is the correct way to bill for the patient education sessions performed by registered nurses to individual patients prior to their IVF cycle? View the Answer
Pregnancy Ultrasound
Our practice does routine ultrasounds (sac check- 76817) at the end of an IVF cycle and bill with a diagnosis code O09.081, pregnancy resulting from ART. View the Answer
In Vitro Maturation
Have CPT codes been established for maturation in vitro? View the Answer
IUI or IVF
Should other ovarian dysfunction (diagnosis code E28.8) or unspecified ovarian dysfunction (diagnosis code E28.9) can be used for an IUI or an IVF cycle View the Answer
IV Fluids During Egg Retrieval
Is it appropriate to bill the insurance company for CPT 96360, Under Hydration Infusion when being used in conjunction with IVF retrieval? View the Answer
IVF Billing Forms
I am seeking information on IVF insurance billing guidelines. View the Answer
IVF Billing Globally
Am I correct in assuming that it is duplicate billing for both the ambulatory center and embryology laboratory to bill globally? View the Answer
IVF Billing of Professional Charges
Are we allowed to bill professional charges under the physician for the embryologist who performs the IVF laboratory services? View the Answer
IVF Case Rates
What ICD-10 codes apply to case rates? View the Answer
IVF Consent Counseling
When a patient is scheduled to undergo IVF and the provider schedules the patient for a 30-minute consultation is this visit billable? View the Answer
Lab Case Rates
What ICD-10 codes apply to case rates? View the Answer
Oocyte Denudation
Is there is a separate code for denudation of oocytes? View the Answer
Ovulation Induction Monitoring for IUI
We would like to clarify the correct ICD 10 diagnosis code for monitoring of an IUI cycle. View the Answer
Endometrial Biopsy/Scratch
What CPT code should be used for a “scratch test”? View the Answer
Endometriosis and Infertility
For treatment like IVF would we bill with N97.x first or an endometriosis diagnosis? View the Answer
Follicle Monitoring For Diminished Ovarian Reserve
If a patient has decreased ovarian reserve (ICD-10 E28.8) and patient is undergoing follicle tracking to undergo either an IUI cycle or IVF cycle... View the Answer
Global Billing Vs Billing Under Provider
For an IVF cycle (that is not being billed global to an insurance plan) is it appropriate to bill the charges under one “global” provider? View the Answer
Donor Embryos
Could you give guidance for the correct ICD-10 code(s) to use when a patient is doing an Anonymous Donor Embryo Transfer cycle? View the Answer
Egg Culture and Fertilization
We are billing for the technical component of 89250 and would like to also bill a professional component of the 89250. View the Answer
Egg Culture and Fertilization: Same Gender
A same-sex male couple requested half their donor eggs be fertilized with sperm from male #1 and the other half fertilized from male #2. View the Answer
Diagnosis of Infertility for IVF Procedure
How important is it to have accurate documentation of the type of infertility diagnosis for IVF procedures? View the Answer
Journal Club Global: Natural versus Programmed FET Cycles
A significant portion of IVF cycles now utilize frozen embryo transfer.
View the Video
Role of assisted hatching in in vitro fertilization: a guideline (2022)
There is moderate evidence that assisted hatching does not significantly improve live birth rates in fresh assisted reproductive technology cycles View the Committee Opinion
Journal Club Global - Best Practices of High Performing ART Clinics
This Fertility and Sterility Journal Club Global discusses February’s seminal article, “Common practices among consistently high-performing in vitro fertilization programs in the United States: a 10 year update.” View the Video
Guidance on the limits to the number of embryos to transfer: a committee opinion (2021)
ASRM's guidelines for the limits on the number of embryos to be transferred during IVF cycles have been further refined ... View the Committee Opinion
Journal Club Global Live from India - Adjuvants in IVF and IVF Add-Ons for the Endometrium
Many adjuvants have been utilized by IVF centers to improve their success rates. View the Video
Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline (2021)
A review of oocyte cryopreservatino for donor oocyte IVF and planned oocyte cryopreservation success rates, factors that may impact success rates, and outcomes. View the Committee Opinion
Development of an emergency plan for in vitro fertilization programs: a committee opinion (2021)
All IVF programs and clinics should have a plan to protect fresh and cryopreserved human specimens (embryos, oocytes, sperm). View the Committee Opinion
In vitro maturation: a committee opinion (2021)
The results of in vitro maturation (IVM) investigations suggest the potential for wider clinical application. View the Committee Opinion
Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion (2019)
The Ethics Committee recommends that in vitro fertilization (IVF) centers develop patient-centered policies regarding requests for futile treatment. View the Committee Opinion
Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion (2018)
The purposes of this document is to review the literature regarding the clinical application of blastocyst transfer. View the Committee Opinion
The role of immunotherapy in in vitro fertilization: a guideline (2018)
Adjuvant immunotherapy treatments in in vitro fertilization (IVF) aim to improve the outcome of assisted reproductive technology (ART) in both the general ART population as well as subgroups such as patients with recurrent miscarriage or implantation failure. View the Committee Opinion
Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline (2018)
Mild-stimulation protocols with in vitro fertilization (IVF) generally aim to use less medication than conventional IVF. View the Guideline
Performing the embryo transfer: a guideline (2017)
A systematic review of the literature was conducted which examined each of the major steps of embryo transfer. Recommendations made for improving pregnancy rates are based on interventions demonstrated to be either beneficial or not beneficial. (Fertil Steril® 2017;107:882–96. ©2017 by American Society for Reproductive Medicine.) View the Committee Guideline
Best practices of ASRM and ESHRE: a journey through reproductive medicine (2012)
ASRM and ESHRE are the two largest societies in the world whose members comprise the major experts and professionals working in reproductive medicine. View the Committee Joint Guideline
